Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4146-4153
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4146
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4146
Group | Example number | HPV E6/E7 mRNA | HPV (PCR-reverse point hybridization) | ||
Positive | Negative | Positive | Negative | ||
CINI level | 48 | 13 (27.1) | 35 (72.9) | 15 (31.3) | 33 (68.7) |
CIN II level | 31 | 24 (77.4) | 7 (22.6) | 21 (67.7) | 10 (32.3) |
CIN III level | 16 | 12 (75.0) | 4 (25.0) | 11 (68.7) | 5 (31.3) |
Squamous or adenocarcinoma | 5 | 3 (18.8) | 2 (12.5) | 4 (25.0) | 1 (6.3) |
χ2 | 23.483 | 14.669 | |||
P value | < 0.001 | 0.002 |
- Citation: Zhang LL, Du MY, Du X, Duan J, Yao DM, Jing J, Feng C, Song L. Correlation analysis of human papillomavirus E6/E7 mRNA detection with diagnosis, prognosis and recurrence risk in patients with cervical epithelioma. World J Clin Cases 2024; 12(20): 4146-4153
- URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4146.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4146